| [1] |
Luigino C, Paola R,Clive P, et al.Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways[J]. Pulm Pharmacol Ther, 2019, 56:39-50.
|
| [2] |
Wedzicha J, Calverley P, Anzueto AR, et al.The impact of GOLD stage on the effectiveness of tiotropium/olodaterol in preventing COPD exacerbations in the DYNAGITO trial[J]. Thorax, 2019, 74(2):119-121.
|
| [3] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013 年修订版)[J]. 中华结核和呼吸杂志, 2013, 36(4):255-264.
|
| [4] |
Hoogendoorn M, Ramos IC, Baldwin M, et al.Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14(1):447-456.
|
| [5] |
Hazari AAB.Safety and efficacy of tiotropium bromide compared with placebo in COPD and Bronchial Asthma[J]. Indian J Pharm Pharmacol ,2019, 6(4):145-148.
|
| [6] |
Yildiz BP, Bayraktaroglu M, Gunen H.Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a discair inhaler), tiotropium alone or combined with formoterol in adults with moderate-to-severe stable COPD[J]. Curr Med Res Opin, 2019, 35(12):2187-2196.
|
| [7] |
Kamei T, Nakamura H, Nanki N, et al.Clinical benefit of two-times-per-day aclidinium bromide compared with once-a-day tiotropium bromide hydrate in COPD: a multicentre, open-label, randomised study[J]. BMJ Open, 2019, 9(7):241-243.
|
| [8] |
耿培娜, 张龙, 曹丽丽,等. 噻托溴铵与沙美特罗替卡松联合吸入治疗稳定期慢性阻塞性肺疾病的疗效观察[J]. 中国医院用药评价与分析, 2019, 19(4):448-450.
|
| [9] |
韩芳芳, 韩晓惠, 温少虎,等. 噻托溴铵联合舒利迭对COPD急性期并发呼吸衰竭患者肺功能的改善作用[J]. 临床医学研究与实践, 2019, 4(1):35-36.
|
| [10] |
Steinmetz KO, Abenhardt B, Pabst S, et al.Assessment of physical functioning and handling of tiotropium/olodaterol respimat in patients with COPD in a real-world clinical setting[J]. Int J COPD, 2019, 14(1):1441-1453.
|
| [11] |
Kawachi S, Fujimoto K.Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study[J]. Int J COPD, 2019, 6(3):1167-1176.
|
| [12] |
Berton DC, Marques RD, Palmer B, et al.Effects of lung deflation induced by tiotropium/olodaterol on the cardiocirculatory responses to exertion in COPD[J]. Respir Med, 2019, 15(7):1932-1935.
|
| [13] |
Valipour A, Tamm M, Jana K, et al.Improvement in self-reported physical functioning with tiotropium/olodaterol in central and eastern European COPD patients[J]. Int J COPD, 2019, 8(6):2343-2354.
|
粤公网安备 44011302000297号 